Colgate-Palmolive Company (NYSE:CL – Get Free Report) has earned an average rating of “Moderate Buy” from the sixteen research firms that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $89.4375.
Several equities research analysts recently weighed in on CL shares. TD Cowen reduced their target price on shares of Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating for the company in a research note on Thursday, January 8th. Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. The Goldman Sachs Group decreased their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Finally, Raymond James Financial decreased their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th.
Check Out Our Latest Stock Analysis on CL
Institutional Inflows and Outflows
Colgate-Palmolive Trading Down 0.8%
Shares of CL stock opened at $84.72 on Thursday. The firm has a market capitalization of $68.29 billion, a P/E ratio of 23.73, a price-to-earnings-growth ratio of 5.79 and a beta of 0.30. Colgate-Palmolive has a 1 year low of $74.54 and a 1 year high of $100.18. The firm’s fifty day simple moving average is $79.75 and its 200 day simple moving average is $81.60. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same period last year, the business posted $0.91 EPS. The business’s quarterly revenue was up 1.9% on a year-over-year basis. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is 58.26%.
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
